The 5th Commercializing Clinically Validated Digital Therapeutics Summit, designed with DTx companies, pharma and clinicians, will return this December to address the industry’s major challenges such as improving user experience, clinical trial development, and standing out in a crowded market through open discussion and case-study led presentations.  

Whether you’re a veteran at commercializing clinically validated digital therapeutics, looking for partnerships, or a new entrant to the field, you’ll leave this conference with practical lessons and essential connections needed to supercharge DTx commercial ambitions across 2022 and beyond.

To know more visit: https://ter.li/5e6hqd